Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
Condition: COVID-19 Pneumonia Interventions: Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells; Drug: Antibiotics; Drug: Hormones; Drug: Anticoagulant Therapy; Device: Оxygen therapy Sponsors: Institute of Cell Therapy; Kyiv City Clinical Hospital # 4 Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials